Results 211 to 220 of about 285,668 (244)
Some of the next articles are maybe not open access.

5-HT antagonists and blockade of neuronal (5-HT) receptors on ganglion cells

General Pharmacology: The Vascular System, 1984
Potential changes in superior cervical ganglion cells evoked by 5-HT or the nicotinic agonist, dimethyl-phenyl piperazinium (DMPP), were recorded using the sucrose-gap method and a number of putative 5-HT antagonists tested for potency and selectivity. Selective blockade of 5-HT responses was produced by 5-HT itself and, in increasing order of potency,
H L, Nash, D I, Wallis, G, Ash
openaire   +2 more sources

Role of Somatodendritic 5‐HT Autoreceptors in Modulating 5‐HT Neurotransmissiona

Annals of the New York Academy of Sciences, 1998
ABSTRACT: A very important element controlling serotonin (5‐HT) release throughout the brain is the 5‐HT1A autoreceptor present on the soma and dendrites of 5‐HT neurons since it exerts a negative feedback influence on their firing activity. This 5‐HT1A autoreceptor receives an increased activation by endogenous 5‐HT at the beginning of a treatment ...
P, Blier   +4 more
openaire   +2 more sources

Expression of 5‐HT2A, 5‐HT2B and 5‐HT2C receptors in the mouse embryo

International Journal of Developmental Neuroscience, 2000
AbstractExpression patterns of 5‐HT2A, 5‐HT2B and 5‐HT2C receptors during mouse embryogenesis were investigated using highly specific monoclonal antibodies. Differential and overlapping spatio‐temporal patterns of 5‐HT2A, 5‐HT2B and 5‐HT2C receptor immunoreactivity were observed during active phases of morphogenesis of a variety of embryonic tissues ...
J M, Lauder   +3 more
openaire   +2 more sources

5-HT-la and 5-HT-lb selectivity of two phenylpiperazine derivatives: Evidence for 5-HT-lb heterogeneity

Life Sciences, 1985
The ability of m-trifluoromethylphenylpiperazine (TFMPP) and an N-substituted derivative, LY 165163 (p-NH2-PE-TFMPP), to discriminate 5-HT-1 binding sites labelled by [3H]5-HT is compared in rat corpus striatum and rat cortex. TFMPP displays at least a 30 fold selectivity for the 5-HT-1b subtype. Furthermore, TFMPP reveals heterogeneity within the 5-HT-
Kenneth B. Asarch   +2 more
openaire   +2 more sources

Platelet Serotonin (5‐HT) and 5‐HT Releasing Factor in Plasma of Migrainous Patients

Headache: The Journal of Head and Face Pain, 1979
SYNOPSIS The mean platelet 5‐HT concentration in 24 migrainous patients during headache‐free intervals (580 ± 53.3 ng10 9 platelets, M ± SEM) was similar to that found in 25 healthy persons (550 ± 48.1).
Muck-Šeler, Dorotea   +2 more
openaire   +3 more sources

Characterisation of heteromeric 5-HT₃ receptors: a focus on the 5-HT₃C and 5-HT₃E subunits

2017
5-HT₃ receptors are ligand-gated cation channels present in both central and peripheral nervous systems. 5-HT₃ receptor antagonists are used clinically for a range of disorders including irritable bowel syndrome, chemotherapy-induced nausea and depression but have varying efficacy. 5-HT₃ receptors potentially contain five different subunits (A, B, C, D
openaire   +1 more source

Serotonin (5‐HT) and Migraine

Headache: The Journal of Head and Face Pain, 1994
SYNOPSIS Serotonin, or 5‐hydroxytryptamine [5‐HT], is a biogenic amine implicated in controlling feeding behavior, thermoregulation, sexual behavior, and sleep. 5‐HT receptors recognize at least three types of molecular structures: G protein coupled receptors, ligand gated ion channels, and transporters.
openaire   +2 more sources

5-HT and bone biology

Current Opinion in Pharmacology, 2011
Bone formation and bone resorption, the two processes occurring constantly and in a balanced fashion throughout the skeleton, are regulated by signals as various as local and low range growth factors, hormones, and neuronal outputs. Adding to the long list of molecules involved in these regulations, gut-derived and brain-derived serotonin were recently
openaire   +2 more sources

5-HT and physical illness

Journal of Psychopharmacology, 1993
The discovery and clinical evolution of 5-HT re-uptake inhibiting drugs are reviewed. From the widespread distribution of 5-HT in bodily systems and the range of effects and side effects reported, it is concluded that these and other drugs active on the 5-HT system are likely to have beneficial effects on a range of other physical conditions coincident
openaire   +2 more sources

Discriminating between 5-HT₃A and 5-HT₃AB receptors.

British journal of pharmacology, 2014
The 5-HT3B subunit was first cloned in 1999, and co-expression with the 5-HT3A subunit results in heteromeric 5-HT₃AB receptors that are functionally distinct from homomeric 5-HT₃A receptors. The affinities of competitive ligands at the two receptor subtypes are usually similar, but those of non-competitive antagonists that bind in the pore often ...
A J, Thompson, S C R, Lummis
openaire   +1 more source

Home - About - Disclaimer - Privacy